Irisin and myonectin regulation in the insulin resistant muscle: Implications to adipose tissue: Muscle crosstalk

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Gamas, Luis ^a   Matafome, Paulo ^a,b   Seicą, Raquel ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b POLYTECHNIC INSTITUTE OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

IRISIN; ISOPROTEIN; MYONECTIN; UNCLASSIFIED DRUG; C1QTNF5 PROTEIN, HUMAN; COLLAGEN; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADIPOCYTE; ADIPOSE TISSUE; BROWN ADIPOSE TISSUE; EXERCISE; FATTY ACID TRANSPORT; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; IN VITRO STUDY; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIPID OXIDATION; LIPOTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE; THERMOGENESIS; ANIMAL; CELL COMMUNICATION; METABOLISM; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; CELL COMMUNICATION; COLLAGEN; DIABETES MELLITUS, TYPE 2; EXERCISE; FIBRONECTINS; HUMANS; INSULIN RESISTANCE; MUSCLE, SKELETAL; OBESITY;

EID: 84929646308     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/359159     Document Type: Review

References (74)

1. A. Negre-Salvayre, R. Salvayre, N. Augé, R. Pamplona, and M. Portero-Otń, "Hyperglycemia and glycation in diabetic complications, " Antioxidants and Redox Signaling, vol. 11, no. 12, pp. 3071-3109, 2009.
2. E. Bugianesi, A. J. McCullough, and G. Marchesini, "Insulin resistance: a metabolic pathway to chronic liver disease, " Hepatology, vol. 42, no. 5, pp. 987-1000, 2005.
3. American Diabetes Association, "Diagnosis and classification of diabetes mellitus, " Diabetes Care, vol. 37, supplement 1, pp. S81-S90, 2013.
4. M. Qatanani and M. A. Lazar, "Mechanisms of obesityassociated insulin resistance: many choices on themenu, " Genes and Development, vol. 21, no. 12, pp. 1443-1455, 2007.
5. M. A. Abdul-Ghani and R. A. Defronzo, "Pathogenesis of insulin resistance in skeletalmuscle, " Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 476279, 19 pages, 2010.
6. L. Chow, A. From, and E. Seaquist, "Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction, "Metabolism:Clinical and Experimental, vol. 59, no. 1, pp. 70-85, 2010.
7. F. Dela and J. W. Helge, "Insulin resistance and mitochondrial function in skeletal muscle, " The International Journal of Biochemistry & Cell Biology, vol. 45, no. 1, pp. 11-15, 2013.
8. K. E.Wellen and G. S. Hotamisligil, "Inflammation, stress, and diabetes, "The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111-1119, 2005.
9. A. Guilherme, J. V. Virbasius, V. Puri, and M. P. Czech, "Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes, " Nature ReviewsMolecular Cell Biology, vol. 9, no. 5, pp. 367-377, 2008.
10. P. Lefebvre, G. Chinetti, J.-C. Fruchart, and B. Staels, "Sorting out the roles of PPARα in energy metabolism and vascular homeostasis, " The Journal of Clinical Investigation, vol. 116, no. 3, pp. 571-580, 2006.
11. K. Moeschel, A. Beck, C. Weigert et al., "Protein kinase C-α-induced phosphorylation of Ser 318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1, "TheJournal of Biological Chemistry, vol. 279, no. 24, pp. 25157-25163, 2004.
12. G. Boden, P. She, M. Mozzoli et al., "Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-αbpathway inrat liver, " Diabetes, vol. 54, no. 12, pp. 3458-3465, 2005.
13. L. Lionetti, M. P. Mollica, A. Lombardi, G. Cavaliere, G. Gifuni, and A. Barletta, "From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation, " Nutrition, Metabolism & Cardiovascular Diseases, vol. 19, no. 2, pp. 146-152, 2009.
14. K. Eckardt, S. W. Görgens, S. Raschke, and J. Eckel, "Myokines in insulin resistance and type 2 diabetes, " Diabetologia, vol. 57, no. 6, pp. 1087-1099, 2014.
15. B. K. Pedersen and M. A. Febbraio, "Muscles, exercise and obesity: skeletal muscle as a secretory organ, " Nature Reviwes, Endocrinology, vol. 8, no. 8, pp. 457-465, 2012.
16. M. M. Seldin, J. M. Peterson, M. S. Byerly, Z. Wei, and G. W. Wong, "Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis, " The Journal of Biological Chemistry, vol. 287, no. 15, pp. 11968-11980, 2012.
17. L. Pedersen and P. Hojman, "Muscle-to-organ cross talk mediated by myokines, " Adipocyte, vol. 1, no. 3, pp. 164-167, 2012.
18. B. K. Pedersen and C. Brandt, "The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases, " Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 520258, 6 pages, 2010.
19. N. Mathur and B. K. Pedersen, "Exercise as a mean to control low-grade systemic inflammation, " Mediators of Inflammation, vol. 2008, Article ID109502, 6 pages, 2008.
20. J. Orava, P. Nuutila, M. E. Lidell et al., "Different metabolic responses of human brown adipose tissue to activation by cold and insulin, " Cell Metabolism, vol. 14, no. 2, pp. 272-279, 2011.
21. A. M. Cypess, S. Lehman, G.Williams et al., "Identification and importance of brown adipose tissue in adult humans, " The New England Journal ofMedicine, vol. 360, no. 15, pp. 1509-1517, 2009.
22. W. D. van Marken Lichtenbelt, J. W. Vanhommerig, N. M. Smulders et al., "Cold-activated brown adipose tissue in healthy men, "The New England Journal ofMedicine, vol. 360, no. 15, pp. 1500-1508, 2009.
23. G. H. E. J. Vijgen, N. D. Bouvy, G. J. J. Teule, B. Brans, P. Schrauwen, andW. D. vanMarken Lichtenbelt, "Brown adipose tissue in morbidly obese subjects, " PLoS ONE, vol. 6, no. 2, Article ID e17247, 2011.
24. J. Wu, P. Boström, L. M. Sparks et al., "Beige adipocytes are a distinct type of thermogenic fat cell inmouse and human, " Cell, vol. 150, no. 2, pp. 366-376, 2012.
25. P. Boström, J. Wu, M. P. Jedrychowski et al., "A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis, " Nature, vol. 481, no. 7382, pp. 463-468, 2012.
26. J. I. Castillo-Quan, "Fromwhite to brown fat through the PGC-1α-dependent myokine irisin: implications for diabetes and obesity, " Disease Models and Mechanisms, vol. 5, no. 3, pp. 293-295, 2012.
27. P. Lee, J. D. Linderman, S. Smith et al., "Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans, " Cell Metabolism, vol. 19, no. 2, pp. 302-309, 2014.
28. Y. Zhang, R. Li, Y. Meng et al., "Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERKMAP kinase signaling, " Diabetes, vol. 63, no. 2, pp. 514-525, 2014.
29. P. J. Scarpace, S. Yenice, and N. Tümer, "Influence of exercise training and age on uncoupling protein mRNA expression in brown adipose tissue, " Pharmacology Biochemistry and Behavior, vol. 49, no. 4, pp. 1057-1059, 1994.
30. R. De Matteis, F. Lucertini, M. Guescini et al., "Exercise as a new physiological stimulus for brown adipose tissue activity, " Nutrition, Metabolism & Cardiovascular Diseases, vol. 23, no. 6, pp. 582-590, 2013.
31. C. D.Wrann, J. P.White, J. Salogiannnis et al., "Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway, " Cell Metabolism, vol. 18, no. 5, pp. 649-659, 2013.
32. T. L. Rachid, A. Penna-de-Carvalho, I. Brighenti, M. B. Aguila, C. A. Mandarim-de-Lacerda, and V. Souza-Mello, "Fenofibrate (PPARalfa agonist) induces beige cell formation in subcutaneous white adipose tissue fromdiet-inducedmale obese mice, " Molecular and Cell Endocrinology, vol. 402, pp. 86-94, 2015.
33. B. M. Spiegelman, "Banting lecture 2012: regulation of adipogenesis: toward new therapeutics for metabolic disease, " Diabetes, vol. 62, no. 6, pp. 1774-1782, 2013.
34. X. Xu, Z. Ying, M. Cai et al., "Exercise ameliorates high-fat diet-inducedmetabolic and vascular dysfunction, and increases adipocyte progenitor cell population in brown adipose tissue, " TheAmerican Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 300, no. 5, pp. R1115-R1125, 2011.
35. A. Roca-Rivada, C. Castelao, L. L. Senin et al., "FNDC5/irisin is not only a myokine but also an adipokine, " PLoS ONE, vol. 8, no. 4, Article ID e60563, 2013.
36. F. Norheim, T. M. Langleite, M. Hjorth et al., "The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans, "The FEBS Journal, vol. 281, no. 3, pp. 739-749, 2014.
37. T. Kurdiova, M. Balaz, A. Mayer et al., "Exercise-mimicking treatment fails to increase Fndc5 mRNA & irisin secretion in primary human myotubes, " Peptides, vol. 56, pp. 1-7, 2014.
38. A. Besse-Patin, E. Montastier, C. Vinel et al., "Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine, " International Journal of Obesity, vol. 38, no. 5, pp. 707-713, 2014.
39. J. A. Timmons, K. Baar, P. K. Davidsen, and P. J. Atherton, "Is irisin a human exercise gene?" Nature, vol. 488, no. 7413, pp. E9-E10, 2012.
40. S. Raschke, M. Elsen, H. Gassenhuber et al., "Evidence against a beneficial effect of irisin in humans, " PLoS ONE, vol. 8, no. 9, Article ID e73680, 2013.
41. S. Pekkala, P. K.Wiklund, J. J. Hulmi et al., "Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health?" The Journal of Physiology, vol. 591, no. 21, pp. 5393-5400, 2013.
42. T. Kurdiova, M. Balaz, M. Vician et al., "Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletalmuscle and adipose tissue: in vivo and in vitro studies, " The Journal of Physiology, vol. 592, no. 5, pp. 1091-1107, 2014.
43. S. Aydin, T. Kuloglu, M. Yilmaz, M. Kalayci, I. Sahin, and D. Cicek, "Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45 min of a Turkish bath or running, " Peptides, vol. 50, pp. 13-18, 2013.
44. A. Hecksteden, M.Wegmann, A. Steffen et al., "Irisin and exercise training in humans-results from a randomized controlled training trial, " BMC Medicine, vol. 11, no. 1, article 235, 2013.
45. J. Brenmoeh, E. Albrecht, K. Komolka et al., "Irisin is elevated in skeletal muscle and serum of mice immediately after acute exercise, " International Journal of Biological Sciences, vol. 10, no. 3, pp. 338-349, 2014.
46. J. Y. Huh, G. Panagiotou, V. Mougios et al., "FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise, " Metabolism: Clinical and Experimental, vol. 61, no. 12, pp. 1725-1738, 2012.
47. S. Ellefsen, O. Vikmoen, G. Slettaløkken et al., "Irisin and FNDC5: effects of 12-week strength training, and relations to muscle phenotype and body mass composition in untrained women, " European Journal of Applied Physiology, vol. 114, no. 9, pp. 1875-1888, 2014.
48. J. Y. Huh, V. Mougios, A. Kabasakalis et al., "Exercise-induced irisin secretion is independent of age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation, " The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 11, pp. E2154-E2161, 2014.
49. A. D. Anastasilakis, S. A. Polyzos, Z. G. Saridakis et al., "Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and association with gender, physical activity, diet, and body composition, " The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 9, pp. 3247-3255, 2014.
50. D. Löffler, U.Müller, K. Scheuermann et al., "Serumirisin levels are regulated by acute strenuous exercise, "The Journal ofClinical Endocrinology & Metabolism, vol. 100, no. 4, pp. 1289-1299, 2015.
51. Y. Tsuchiya, D. Ando, K. Goto, M. Kiushi, M. Yamakita, and K. Koyama, "High-intensity exercise causes greater irisin response compared with low-intensity exercise under similar energy consumption, " The Tohoku Journal of Experimental Medicine, vol. 233, no. 2, pp. 135-140, 2014.
52. T. Hew-Butler, K. Landis-Piwowar, G. Byrd et al., "Plasma irisin in runners and non-runners: no favorablemetabolic association in humans, " Physiological Reports, vol. 3, no. 1, Article IDe12262, 2015.
53. M. Elsen, S. Raschke, and J. Eckel, "Browning of white fat: does irisin play a role in humans?" The Journal of Endocrinology, vol. 222, no. 1, pp. 25-38, 2014.
54. K. Højlund and P. Boström, "Irisin in obesity and type 2 diabetes, " Journal of Diabetes and Its Complications, vol. 27, no. 4, pp. 303-304, 2013.
55. H. J. Lee, J. O. Lee, N. Kim et al., "Irisin, a novel myokine, regulates glucose uptake in skeletal muscle cells via AMPK, " Molecular Endocrinology, 2015.
56. R. A. Vaughan, N. P. Gannon, M. A. Barberena et al., "Characterization of the metabolic effects of irisin on skeletal muscle in vitro, " Diabetes, Obesity and Metabolism, vol. 16, no. 8, pp. 711-718, 2014.
57. M. M. Seldin and G. W. Wong, "Regulation of tissue crosstalk by skeletal muscle-derived myonectin and other myokines, " Adipocyte, vol. 1, no. 4, pp. 200-202, 2012.
58. M. M. Seldin, X. Lei, S. Y. Tan, K. P. Stanson, Z. Wei, and G. W. Wong, "Skeletal muscle-derived myonectin activates the mammalian target of rapamycin (mTOR) pathway to suppress autophagy in liver, " The Journal of Biological Chemistry, vol. 288, no. 50, pp. 36073-36082, 2013.
59. J. M. Moreno-Navarrete, F. Ortega, M. Serrano et al., "Irisin is expressed and produced by humanmuscle and adipose tissue in association with obesity and insulin resistance, " The Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 4, pp. 769-778, 2013.
60. M. Zhang, P. Chen, S. Chen et al., "The association of new inflammatory markers with type 2 diabetes mellitus andmacrovascular complications: a preliminary study, " European Review for Medical and Pharmacological Sciences, vol. 18, no. 11, pp. 1567-1572, 2014.
61. C. Zhang, Z. Ding, G. Lv, J. Li, P. Zhou, and J. Zhang, "Lower irisin level in patients with type 2 diabetes mellitus: a casecontrol study and meta-analysis, " Journal of Diabetes, 2014.
62. R. Alis, F. Sanchis-Gomar, H. Pareja-Galeano et al., "Association between irisin and homocysteine in euglycemic and diabetic subjects, " Clinical Biochemistry, vol. 47, no. 18, pp. 333-335, 2014.
63. J.-J. Liu, M. D. S.Wong, W.C.Toy et al., "Lower circulating irisin is associated with type 2 diabetes mellitus, " Journal of Diabetes and Its Complications, vol. 27, no. 4, pp. 365-369, 2013.
64. Y.-K. Choi, M.-K. Kim, K. H. Bae et al., "Serum irisin levels in new-onset type 2 diabetes, " Diabetes Research and Clinical Practice, vol. 100, no. 1, pp. 96-101, 2013.
65. L. Xiang, G. Xiang, L. Yue, J. Zhang, and L. Zhao, "Circulating irisin levels are positively associated with endotheliumdependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy, " Atherosclerosis, vol. 235, no. 2, pp. 328-333, 2014.
66. B. Yan, X. Shi, H. Zhang et al., "Association of serum irisin with metabolic syndrome in obese chinese adults, " PLoS ONE, vol. 9, no. 4, Article ID e94235, 2014.
67. M. Pardo, A. B. Crujeiras, M. Amil et al., "Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index, " International Journal of Endocrinology, vol. 2014, Article ID 857270, 9 pages, 2014.
68. A. Stengel, T. Hofmann, M. Goebel-Stengel, U. Elbelt, P. Kobelt, and B. F. Klapp, "Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with bodymass index, " Peptides, vol. 39, no. 1, pp. 125-130, 2013.
69. A. B. Crujeiras, M. Pardo, A. Roca-Rivada et al., "Longitudinal variation of circulating irisin after an energy restrictioninduced weight loss and following weight regain in obese men and women, " American Journal of Human Biology, vol. 26, no. 2, pp. 198-207, 2014.
70. G. Panagiotou, L. Mu, B. Na, K. J. Mukamal, and C. S. Mantzoros, "Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk, " Metabolism, vol. 63, no. 10, pp. 1265-1271, 2014.
71. J. M. Peterson, R. Mart, and C. E. Bond, "Effect of obesity and exercise on the expression of the novel myokines, Myonectin and Fibronectin type III domain containing 5, " PeerJ, vol. 2, article e605, 2014.
72. A. Rodŕ?guez, S. Becerril, L. Méndez-Giménez et al., "Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice, " International Journal of Obesity, vol. 39, no. 3, pp. 397-407, 2014.
73. N. Sharma, C. M. Castorena, and G. D. Cartee, "Greater insulin sensitivity in calorie restricted rats occurswith unaltered circulating levels of several importantmyokines and cytokines, " Nutrition & Metabolism, vol. 9, article 90, 2012.
74. M. Yang, D. Wei, C. Mo et al., "Saturated fatty acid palmitateinduced insulin resistance is accompanied with myotube loss and the impaired expression of health benefit myokine genes in C2C12 myotubes, " Lipids in Health and Disease, vol. 12, article 104, 2013.